Key Takeaways
- Profit nearly doubles, but volumes shrink: PAT grew ~100% YoY in Q2, yet H1 volumes fell ~4%, exposing a tension between margin-rich mix shifts and demand-side volume pressure concentrated in AMET.
- AMET volume collapse is the quarter's scar: A 19% H1 volume decline in Africa, Middle East, Turkey, driven by Egypt's 55% currency depreciation and a local competitor gaining share, wiped out ~30,000 metric tons that could not be placed elsewhere.
- EBITDA per ton runs hot, guidance revised up: EBITDA per metric ton hit Rs. 22,000-26,000 for three straight quarters, well above the prior Rs. 16,000-18,000 band, prompting management to raise full-year guidance to Rs. 21,000-22,000.
- Specialty care's European problem: Rest-of-world specialty volumes grew 3.5% H1, but Europe, a big market for mild surfactants and preservatives, is not measuring up, and new product inductions are stalling on weak sentiment.
- What to watch next quarter: Whether Egypt and Turkey volumes begin their promised 3-to-6-month recovery, whether Europe's demand sentiment turns for specialty care, and whether the US inventory correction deepens or stabilizes.
AMET: The Concentrated Hit
- Egypt at the epicenter: The local Egypt market, representing 33%-45% of AMET volumes, suffered a 55% currency depreciation over eight months, triggering down-trading, demand cutbacks, and a share shift to a local backward-integrated player at the expense of Galaxy's customers.
- Turkey compounded the pain: Turkey's currency devalued more than 100% over several years, with inflationary pressure building progressively over 9 to 12 months, eroding demand and disrupting trade flows.
- No geographic offset available: The ~30,000 metric ton volume loss could not be placed in Africa, Europe, or Latin America because Africa faced food inflation and supply chain disruption, and Turkey's own inflation and depreciation hit simultaneously across the entire region.
- Recovery anchored to 2016 precedent: Management expects Egypt's volume recovery to start in 4 to 6 months, citing the 2016-17 currency devaluation episode when consumption habits proved resilient and volumes returned once foreign exchange availability normalized. Supply chain conditions have already substantially restored.
- Turkey's export engine may restart: Turkey is an attractive low-cost export destination into Europe and does not face a significant energy crisis; management expects export businesses to resume normalcy, which would in turn restore Galaxy's exports into Turkey.
Kulkarni: "We expect it to more or less follow similar trends. This is what our interaction with our customers in that particular country has shared with us. The consumption of home care and personal care products per se, they are good in the country. The habits are seasoned."
Volume vs. Margin: The Uncomfortable Math
- Volumes declined, EBITDA per ton surged: H1 volumes fell ~4% while EBITDA per metric ton printed at Rs. 22,000-26,000 for three consecutive quarters, driven by product mix, operational improvements, and judicious price calls, but also aided by the volume decline itself and reversal of supply-led factors.
- Management insists volume is the target: Leadership explicitly stated that EBITDA is a derivative, not a target, and that the priority remains growing ahead of the market, with a long-term volume growth aspiration of 6% to 8%.
- FY23 volume aspiration already under water: Full-year volume growth aspiration of 2% to 3% requires a conducive demand environment, but H1 closed at negative ~4%, meaning H2 must deliver a sharp swing that depends on AMET recovery and European stabilization.
- The normalization trade-off: When volume growth returns in a secular trend, EBITDA per ton will automatically adjust; management expects it to settle at the higher end of the Rs. 16,000-18,000 range when AMET and Europe pick up.
- Capacity utilization stuck: Utilization at 67%-68% is not expected to change significantly next year unless the demand environment corrects much more meaningfully.
Natarajan: "We would like to be decoupled from the global macro environment and what happens in Europe in terms of bad demand. But it doesn't work that way."
Specialty Care: Europe Weighs on the Premium Story
- Rest-of-world specialty volumes grew modestly: 3.5% H1 and 7-8% QoQ, but the headline number masks a sharp geographic divergence: the US and Asia Pacific held up well while Europe dragged.
- Europe is the concern: Europe is a big market for mild surfactants, preservatives, and other specialties, and its underperformance is the primary reason specialty care momentum has stalled.
- New product induction frozen: Customers have taken a step back from new product induction in the current demand scenario; management expects this to return once sentiment changes, but offered no timeline.
- US tempering adds caution: The US, a bright spot for specialty care through Q2, is now seeing demand temper and inventory correction by retailers like Walmart and Target, which is passing through the entire value chain.
- The premium penetration thesis is intact but paused: Management's long-term view that EBITDA per ton will secularly move up as the world becomes more premium and penetration increases remains in place, but near-term specialty growth depends on European sentiment turning.
India: The Structural Anchor
- Volumes grew 8% Q2, 5.5% H1: India sustained the structural uptick witnessed during COVID, with inflationary pressures now easing and expected to add further momentum.
- On course for 100,000 metric tons: Management reaffirmed that India is on track to touch the 100,000 metric ton sales milestone, anchoring the portfolio while AMET and Europe remain volatile.
- Mass and mass-tige resilience: India's categories, while capable of a once-in-3-to-4-year decline, were the first to make a comeback in the FY20-FY22 cycle, and management remains optimistic about FY24.
Costs, Projects & Capital Allocation
- Employee cost stepped up: Year-on-year increase reflects normal increments, currency depreciation translation of subsidiary costs into INR, and the flow-through of manpower costs for two projects that moved from pre-capitalization into the P&L. Variable pay provisions also normalized after a muted prior year.
- CAPEX steady at Rs. 150-175 crores per annum: FY23 and FY24 CAPEX continues at this run rate, with no signal of a step-change despite the two newly operational projects.
- Tax rate variability is structural: Subsidiary tax rates depend on the profitability mix of Egypt (zero-tax zone) and Turkey, so variation quarter-to-quarter is inherent and will persist.
- APG on the radar, no disclosure yet: Management acknowledged Alkyl Polyglucoside is on the radar but declined to share plans, saying it will communicate at the appropriate time.
Natarajan: "Yes, you're right. I would be happy if the business followed the rules of mathematics but unfortunately it is not so."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA per metric ton | Rs. 21,000 to 22,000 for full year (revised up from Rs. 16,000-18,000) | FY23 |
| Egypt volume recovery | Recovery to start, following 2016-17 precedent; supply chain substantially restored | 3 to 6 months |
| Turkey export normalization | Export businesses into Europe to resume, restoring Galaxy's exports to Turkey | Implicitly tied to Egypt timeline |
| India volume milestone | On course to touch 100,000 metric tons sales | No date; reaffirmed as on track |
| FY23 volume growth aspiration | 2% to 3% full year, conditional on demand environment turning conducive | FY23 (H1 was ~negative 4%) |
| Long-term volume growth | 6% to 8%, with EBITDA growth 300-400 bps above it and ROCE minimum 22% | Long-term aspiration |
| CAPEX | Rs. 150 to 175 crores per annum | FY23 and FY24 |
| Egypt local market stabilization | May take three to four quarters more | 3-4 quarters |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Revenue mix (India:AMET:RoW) | 40:28:32 for H1 FY23 |
| India volume growth | 8% for Q2, 5.5% for H1 FY23 |
| AMET volume growth | -3.5% for H1 FY23, with Africa, Middle East, Turkey volumes declining 19% |
| Rest of World volume growth | 14% over Q2, 3.6% for H1 FY23 |
| EBITDA per metric ton | Rs. 22,000 to Rs. 26,000 for the past three quarters |
| EBITDA per metric ton guidance (revised) | Rs. 21,000 to Rs. 22,000 for FY23, revised from Rs. 16,000 to 18,000 per metric ton |
| Volume growth aspiration (FY23) | 2% to 3%, with meeting previous year's volumes considered good |
| Long-term volume growth aspiration | 6% to 8%, with EBITDA growth 300 to 400 bps above it |
| Long-term ROCE target | Minimum 22% |
| Capacity utilization | 67% to 68% |
| CAPEX per annum | Rs. 150 to Rs. 175 crores, continuing into FY23-24 |
| Inventory level | Rs. 775 crores in September versus March |
| Fatty alcohol price correction | $1,500, corrected from almost $2,900 at peak |
| Egypt and Turkey share of AMET volumes | 60% to 65% |
| Egyptian pound depreciation | 55% in the last 8 months, from 15.7 to 24.37 per dollar |